Tezcan Gecgil

Tezcan Gecgil

Expertise: ETFs, Options Trading, Technical and Fundamental Analysis

Education: PhD (Business Studies), MSc (Investment Banking & Trading), MBA

Awards & Accomplishments: Completed all 3 levels of the Chartered Market Technician (CMT) qualification

About Tezcan
Tezcan Gecgil, PhD, began contributing to InvestorPlace in 2018. She has worked in investment management in the U.S. and U.K., including a Greenwich, Connecticut-based hedge fund as well as the American Stock Exchange, CFA Institute, and Bloomberg. She has also taught at various U.S. and U.K. universities.

She holds Ph.D. (Business Studies) as well as MSc (Investment Banking & Trading) and MBA degrees from leading U.S. and U.K. universities and has also completed all three levels of the Chartered Market Technician (CMT) examination.

Her passion is for options trading based on technical analysis of fundamentally strong companies. She especially enjoys setting up weekly covered calls for income generation. Publicly, she has also contributed to investing.com and the U.K. website of The Motley Fool. She is also part of the investment management writing team at Copylab.

When not navigating the markets, Tezcan delves into the mysteries of history and explores new destinations.

Recent Articles

7 Hot Food Stocks to Buy for Tasty Returns

Delicious menus, pandemic innovations and solid fundamentals make these seven food stocks great buys right here.

Any Dip in Splunk Stock Is a Great Buying Opportunity

Splunk stock represents the growing data analytics market, and it has a lot of potential. That's why you should buy SPLK shares on any dip.

Zoom Video Releases Q2 Results: What To Expect From ZM Stock in September

ZM stock may come under pressure short-term, but shares in the video communications specialist are likely to reach new highs in the coming quarters

3 Back-to-School Stocks to Buy for September

Here are three school stocks for investors to buy whose most exciting period of growth may well lie in the coming weeks.

Novavax Is Conducting Clinical Trials: The Ride In NVAX Stock Will Continue To Be Wild

NVAX stock has been among the hottest stocks in 2020, but it still remains a risky investment

Electrameccanica Vehicles Likely to See $2.50 Before $5

ElectraMeccanica Vehicles currently has minimal revenue, which makes SOLO stock a risky proposition for investors to make.

Vaccine Race Also-ran iBio Stock Won’t See Earlier Highs Anytime Soon

Both the potential rewards and risks offered by IBIO stock are high. But for Covid-19 vaccine bets, there are better options for investors.

Why GE Shares Will Likely Stay Range-Bound

Due to the pandemic, the promised turnaround in General Electric is not happening yet. So GE stock is likely to be range-bound for now.

Inovio Shares Have Been Hot in 2020 but Watch for a Volatile September

Although Inovio shares have skyrocketed this year as part of the vaccine development efforts, the momentum in INO stock may not not be strong.

3 Stocks to Short as Markets Climb Higher

Given the recent increases in their share prices and valuations, these three businesses top my list of stocks to short.